Rathkey et al. identified necrosulfonamide (NSA) as a potent inhibitor of GSDMD through direct binding to GSDMD to inhibit pyroptosis; it was also efficacious in sepsis models, suggesting that GSDMD inhibitors may be used clinically in infectious and inflammatory diseases75. Here, GSDMD is linked to Sepsis.